Related Experiment Video
Updated: Jul 29, 2025
13:08
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
19.0K
Laboratory Evaluation of Thrombophilia
1Department of Pathology, University of New Mexico, TriCore Reference Laboratories, Albuquerque, NM, USA. RMarlar@salud.unm.edu.
Methods in Molecular Biology (Clifton, N.J.)
|May 19, 2023
Summary
Thrombophilia, a complex condition leading to venous thromboembolism (VTE), requires standardized laboratory testing. Harmonized guidelines are needed for accurate diagnosis and cost-effective VTE patient management.
Area of Science:
- Medical Science
- Hematology
- Clinical Diagnostics
Background:
- Venous thromboembolism (VTE) encompasses deep vein thrombosis and pulmonary embolism, stemming from diverse provoked and unprovoked causes.
- Thrombophilia is an intricate, multifactorial condition contributing to VTE, with incompletely understood mechanisms and pathophysiology.
- Current understanding of thrombophilia's pathophysiology, diagnosis, and prevention remains limited, necessitating further research and clinical application.
Purpose of the Study:
- To elucidate the pathophysiology of thrombophilia and its association with VTE.
- To review and discuss evidence-based medicine guidelines for optimal laboratory testing in VTE patients.
- To advocate for harmonized guidelines in patient selection and testing protocols for inherited and acquired thrombophilia risk factors.
Main Methods:
- Review of existing literature on thrombophilia pathophysiology and VTE.
- Analysis of current laboratory testing practices and variations among providers and laboratories.
- Discussion of evidence-based medicine guidelines for diagnostic algorithms and protocols.
Main Results:
- VTE has multifactorial causes, with thrombophilia being a significant, complex contributor.
- Laboratory analysis for thrombophilia is inconsistently applied and varies significantly.
- There is a need for harmonized guidelines for patient selection and testing conditions for thrombophilia risk factors.
Conclusions:
- Standardized laboratory analysis and harmonized guidelines are crucial for accurate thrombophilia diagnosis and VTE management.
- Implementing evidence-based protocols ensures cost-effective utilization of resources in VTE patient evaluation.
- Further research is needed to fully understand thrombophilia's complex mechanisms and improve diagnostic and preventive strategies.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
775
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
775
01:29Venous Thrombosis III: Interprofessional Care
12
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
12
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
17
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
17
01:24Disorders of Hemostasis
1.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.0K
01:30Venous Thrombosis I: Introduction
14
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
14
01:20Extrinsic and Intrinsic Pathways of Hemostasis
8.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.5K